Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma

单细胞多组学揭示多发性骨髓瘤中CAR T细胞持久性和功能障碍的调控机制

阅读:2

Abstract

Understanding the mechanisms that drive chimeric antigen receptor (CAR) T-cell function and persistence in multiple myeloma (MM) remains a critical challenge for improving therapeutic outcomes. In this study, we applied single-cell multiomics and gene regulatory network analysis to characterize the transcriptional dynamics and clonal evolution of B-cell maturation antigen–targeted CAR T-cells in longitudinally collected bone marrow (BM) and peripheral blood (PB) samples from patients with MM. Our results revealed that CAR T cells infiltrating BM exhibited a more activated and exhausted phenotype than their PB counterparts, with key transcriptional regulators driving these changes. Dysregulation in the effector-to-memory transition led to increased presence of terminally differentiated CAR T-cells, correlating with poor persistence. Additionally, we identified a hyperexpanded CAR T-cell clone in the BM of a patient in partial response, marked by elevated interleukin-10 (IL-10) expression. Functional analyses demonstrated that stimulation of endogenous T-cell receptor (TCR) enhanced IL-10 production, potentially contributing to impaired CAR T-cell proliferation and persistence. These findings uncover regulatory mechanisms influencing CAR T-cell dynamics, offering new insights into improving CAR T-cell persistence and therapeutic efficacy in MM, and highlight potential molecular targets for optimizing CAR T-cell therapy in patients with MM.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。